In an effort to shore up its position in a rapidly developing market for brain-computer interface (BCI) technologies, Onward Medical NV signed an exclusive license with France’s CEA-Clinatec to use its BCI chip as part the Arc-BCI system, which restores direct communication from the brain to the spinal cord. Read More

Borvo Medical Inc., a neurointerventional med-tech startup, reported U.S. FDA 510(k) clearance of its Endoport Vacuum Assisted Collection (EVAC) system, an alternative to traditional subdural hematoma (SDH) drainage methods. The EVAC system is expected to be available in early 2025 the company said. Read More

Third-party litigation funding has been a source of controversy in the U.S. over the past decade, but the practice drew little national scrutiny up to now. Read More

Qnovia Inc. received U.S. FDA clearance to start its clinical trial for Respirx, a nicotine inhaler designed as a replacement therapy for smoking. Read More

Researchers from Harvard Medical School and the Icahn School of Medicine at Mount Sinai found two rare, recurrent patterns of mutation in the post-mortem brain tissue of individuals with schizophrenia that could reflect prenatal mutational processes. Read More

New hires and promotions in the med-tech industry, including: Accuray, Alpha-9 Oncology, Inflamattix, Spectral AI. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sound Health, Orthoxcel. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alife, Alimentiv, Brainscope, CEA, Clinical Microbiomics, Elucid, Endogenex, Firefly Neuroscience, Flatiron Health, Inception Fertility, Inari, Microba, Microbot Medical, Myriad Genetics, Onward Medical, Satisfai Health . Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CMR Surgical, Momentis, Heidelberg. Read More